N-[[4-chloro-3-[4-oxo-6-[5-(trifluoromethyl)-3-pyridinyl]-1,3-diazinan-2-yl]phenyl]methyl]-2-methylpropanamide
C21H22ClF3N4O2 — CID 155883416
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[[4-chloro-3-[4-oxo-6-[5-(trifluoromethyl)-3-pyridinyl]-1,3-diazinan-2-yl]phenyl]methyl]-2-methylpropanamide
N-[[4-chloro-3-[4-oxo-6-[5-(trifluoromethyl)-3-pyridinyl]-1,3-diazinan-2-yl]phenyl]methyl]-2-methylpropanamide (PubChem CID 155883416) has the molecular formula C21H22ClF3N4O2 and a molecular weight of 454.88 g/mol. Its IUPAC name is N-[[4-chloro-3-[4-oxo-6-[5-(trifluoromethyl)-3-pyridinyl]-1,3-diazinan-2-yl]phenyl]methyl]-2-methylpropanamide.
Molecular Properties
| Compound Name | N-[[4-chloro-3-[4-oxo-6-[5-(trifluoromethyl)-3-pyridinyl]-1,3-diazinan-2-yl]phenyl]methyl]-2-methylpropanamide |
|---|---|
| PubChem CID | 155883416 |
| Molecular Formula | C21H22ClF3N4O2 |
| Molecular Weight | 454.88 g/mol |
| Exact Mass | 454.14 |
| IUPAC Name | N-[[4-chloro-3-[4-oxo-6-[5-(trifluoromethyl)-3-pyridinyl]-1,3-diazinan-2-yl]phenyl]methyl]-2-methylpropanamide |
| SMILES | CC(C)C(=O)NCc1ccc(Cl)c(C2NC(=O)CC(c3cncc(C(F)(F)F)c3)N2)c1 |
| InChI | InChI=1S/C21H22ClF3N4O2/c1-11(2)20(31)27-8-12-3-4-16(22)15(5-12)19-28-17(7-18(30)29-19)13-6-14(10-26-9-13)21(23,24)25/h3-6,9-11,17,19,28H,7-8H2,1-2H3,(H,27,31)(H,29,30) |
| InChIKey | NYVSVUBEWWLUJQ-UHFFFAOYSA-N |
| XLogP | 3.88 |
| TPSA | 83.12 Ų |
| H-Bond Donors | 3 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 454.88 |
| LogP ≤ 5 | 3.88 |
| H-Bond Donors ≤ 5 | 3 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155883416 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.